Rothschild bullish on India, expects to close more deals in H22020

Domestic deal activity managed to remain in the green during the first half, thanks to the unprecedented stake sale by Reliance Industries in Jio Platforms, between April and June, worth nearly $15 bn

mergers, firms, deal, companies, pact, agreement
Rothschild's India team is working on deals worth over $4 billion across pharma, IT and power sectors, he said. Photo: Shutterstock
Press Trust of India Mumbai
3 min read Last Updated : Aug 02 2020 | 8:55 PM IST
Even as there is no end in sight for the coronavirus pandemic, which scuppered deal-making activities in the first half of the year, global investment bank Rothschild & Co is bullish on India deal street as it's already working on a pipeline of deals worth billions of dollars.

Domestic deal activity managed to remain in the green during the first half, thanks to the unprecedented stake sale by Reliance Industries in Jio Platforms, between April and June, worth nearly $15 billion (about Rs 1.12 trillion) through 11 deals.

This helped the overall deal-making grow 14.5 per cent to $43.8 billion (about Rs 3.28 trillion) in the first half of 2020, according to numbers collated by Mergermarkets.

According to Aalok Shah, managing director of Rothschild & Co in India, the bank had a reasonably good first half as it completed three large deals -- the $490-million Piramal-Carlyle deal, $900-million Edelwiess-Engie deal, and TVS' buyout of British bike company Norton Motorcycles, and is working on a number of deals which could be completed in the second half.

"We had a decent start to the year with the $900 million Edelwies-Engie deal in January and a couple of more big-ticket deals through the rest of the first half. Currently we have a list of deals in the making," Shah told PTI over the weekend.

"I am confident that we will be closing more deals in the second half than we had done in the first half. Since June, there is lot of traction across sectors and corporate groups, most on the sell-side, making the rest of the year more promising," he added.
Rothschild's India team is working on deals worth over $4 billion across pharma, IT and power sectors, he said.

Listing out IT, pharma and infrastructure, especially power and renewables, as the main activity areas, Shah said he expects $1-2 billion worth of acquisitions by domestic IT companies abroad during the remainder of the year, and at least $1 billion worth of infrastructure deals, which will be led by private equity firms in renewable space.

Similarly, he also sees three-four deals in pharma space, totalling $500-800 million.

With the government pushing ahead with privatisation of six more airports, Shah sees airport divestments as another sub-segment in infrastructure space that can see some action. There could also be some large data centre deals, he added.

From a trend perspective, Shah said a lot of financially stretched companies can exit their non-core businesses.

"The second half is going to be active. Since June the conversations are positive and bullish," he said.

Another key area of activities will be "fundraising by banks for growth capital and also fundraising by corporates, which will be less of debt money and more of equity by way of asset sales," which Shah said "will not be distress sale, but at fair value. No one will be bargaining for any crazy premia."

His optimism comes from the fact that given the pandemic, private equity funds are sitting on "large dry powder to deploy here, and most of them are keen to take advantage of investing in good quality business here as they are commanding lower valuations now."

However, Shah feels the IPO market will continue to remain in the doldrums. "The environment is just not conducive for equity sale now. But if the government succeeds in getting LIC listed then it can change the narrative," he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Pharma sectorIT sectorPower Sector

Next Story